Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetically predicted circulating protein biomarkers and ovarian cancer risk.

Gynecologic oncology - 1 Feb 2021

Considine Daniel P C, Jia Guochong, Shu Xiang, Schildkraut Joellen M, Pharoah Paul D P, Zheng Wei, Kar Siddhartha P

Abstract excerpt

OBJECTIVE: Most women with epithelial ovarian cancer (EOC) are diagnosed after the disease has metastasized and survival in this group remains poor. Circulating proteins associated with the risk of developing EOC have the potential to serve as biomarkers for early detection and diagnosis. We integrated large-scale genomic and proteomic data to identify novel plasma proteins associated with EOC risk. METHODS: We...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Carcinoma, Ovarian Epithelial

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to England

Share to Germ-Line Mutation

Share to Healthy Volunteers

Share to Neoplasm Invasiveness

Share to Ovarian Neoplasms

Share to Risk Assessment

Source

Open in PubMed Open full text

Identifiers

PMID: 33246661
DOI: 10.1016/j.ygyno.2020.11.016
PMCID: PMC7855757

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetically predicted circulating protein biomarkers and ovarian cancer risk.PMID 33246661Read ↗

Multi-omics analysis identifies diagnostic circulating biomarkers and potential therapeutic targets, revealing IQGAP1 as an oncogene in gastric cancerSemantic proximity Read ↗

Proteomic landscape of epithelial ovarian cancer.Semantic proximity Read ↗

Prospective Proteomic Study Identifies Potential Circulating Protein Biomarkers for Colorectal Cancer RiskSemantic proximity Read ↗

Identifying proteomic risk factors for cancer using prospective and exome analyses: 1,463 circulating proteins and risk of 19 cancers in the UK BiobankSemantic proximity Read ↗

Identification of target proteins for breast cancer genetic risk loci and blood risk biomarkers in a large study by integrating genomic and proteomic data.Semantic proximity Read ↗

Assessing the Causal Impact of the Circulating Proteome on Susceptibility to Gastrointestinal Cancer-Associated CharacteristicsSemantic proximity Read ↗

Plasma protein and tumor tissue gene expression analyses in ovarian cancer reveals differentially co-regulated clusters between benign and malignant conditionsSemantic proximity Read ↗

Deep plasma proteomics identifies and validates an eight-protein biomarker panel that separate benign from malignant tumors in ovarian cancerSemantic proximity Read ↗

Genetic variation perspective reveals potential drug targets for subtypes of endometrial cancer.Semantic proximity Read ↗

Mechanistic Insights into Cancer Risk from the Circulating ProteomeSemantic proximity Read ↗

Identification of novel protein biomarkers and drug targets for colorectal cancer by integrating human plasma proteome with genomeSemantic proximity Read ↗

High throughput proteomics identifies a high-accuracy 11 plasma protein biomarker signature for ovarian cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.